FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2002171031> ?p ?o ?g. }

• W2002171031 endingPage "102" @default.
• W2002171031 startingPage "93" @default.
• W2002171031 abstract "Summary The present study was carried out to establish porcine defined IVP. In Experiments 1 and 2, we investigated the efficacy of additional 0.6 mM cystine and/or 100 µM cysteamine (Cys) to a defined TCM199 maturation medium with regard to the intracellular glutathione (GSH) concentration and the developmental competence of in vitro matured porcine oocytes following intracytoplasmic sperm injection (ICSI). The control medium was a modified TCM199 containing 0.05% (w/v) polyvinyl alcohol (PVA). Cys and/or cystine were added to the control medium. The control group and immature oocytes (presumptive germinal vesicle oocytes; GV) were prepared for GSH assay. In Experiment 3, the efficacy of epidermal growth factor (EGF) addition to a modified porcine zygote medium (mPZM) for in vitro culture (IVC) medium was investigated on embryonic development and the mean cell number of blastocysts following ICSI. As a positive or negative control, 0.3% BSA (mPZM-3) or 0.3% PVA (mPZM-4), respectively, was added to the base medium. The defined IVC medium was supplemented with 5 or 10 ng/ml EGF. In Experiment 1, no significant difference was found in the rates of cleavage (31.4–64.3%) and blastocyst formation (6.5–22.9%) among the treatment and control groups. The mean cell numbers per blastocyst ranged from 30 to 48 among the groups without significant differences. However, in Experiment 2, the intracellular GSH concentrations in the oocytes cultured in the medium supplemented with 100 µM Cys (9.6 pmol/oocyte) or Cys + cystine (9.9 pmol/oocyte) were significantly ( p < 0.05) higher than the control (2.5 pmol/oocyte) and 0.6 mM cystine (6.5 pmol/oocyte) groups, but not different from the GV group (9.0 pmol/oocyte). The GSH concentration in the cystine group was also significantly ( p < 0.05) higher than that in the control group, but not different from the GV group. In Experiment 3, the rates of cleavage and blastocyst formation and the mean cell numbers of blastocysts were not significantly different among the groups. However, the addition of 5 ng/ml EGF into the mPZM-4 resulted in a significantly ( p < 0.05) higher blastocyst rate per cleaved embryo than the other two defined groups (mPZM-4 + 5 ng/ml: 48.6%, mPZM-4 and mPZM-4 +10 ng/ml: 23.4% and 23.1%, respectively). The present results indicate that the addition of Cys to a defined medium for in vitro maturation (IVM) of porcine oocytes increases intracellular GSH concentration. Further addition of cystine into the IVM medium containing 100 µM Cys is not necessary and TCM199 plus Cys (100 µM) could be used as a defined IVM medium for porcine oocytes. The addition of 5 ng/ml EGF to a defined IVC medium has enhanced subsequent development after ICSI. This study shows that porcine blastocysts can be produced by defined media throughout the steps of IVP (IVM, ICSI and IVC)." @default.
• W2002171031 created "2016-06-24" @default.
• W2002171031 creator A5007691149 @default.
• W2002171031 creator A5039911435 @default.
• W2002171031 creator A5061711811 @default.
• W2002171031 date "2007-05-01" @default.
• W2002171031 modified "2023-09-30" @default.
• W2002171031 title "Blastocyst production by <i>in vitro</i> maturation and development of porcine oocytes in defined media following intracytoplasmic sperm injection" @default.
• W2002171031 cites W1977057042 @default.
• W2002171031 cites W1980991287 @default.
• W2002171031 cites W1981701710 @default.
• W2002171031 cites W1988600076 @default.
• W2002171031 cites W1993994775 @default.
• W2002171031 cites W2008924154 @default.
• W2002171031 cites W2009455793 @default.
• W2002171031 cites W2014464569 @default.
• W2002171031 cites W2017594387 @default.
• W2002171031 cites W2023146798 @default.
• W2002171031 cites W2025265372 @default.
• W2002171031 cites W2026336054 @default.
• W2002171031 cites W2026843885 @default.
• W2002171031 cites W2028192827 @default.
• W2002171031 cites W2030541670 @default.
• W2002171031 cites W2041019830 @default.
• W2002171031 cites W2057003654 @default.
• W2002171031 cites W2061673419 @default.
• W2002171031 cites W2061833895 @default.
• W2002171031 cites W2062328606 @default.
• W2002171031 cites W2062659820 @default.
• W2002171031 cites W2074347543 @default.
• W2002171031 cites W2076800116 @default.
• W2002171031 cites W2082215944 @default.
• W2002171031 cites W2085189394 @default.
• W2002171031 cites W2085922126 @default.
• W2002171031 cites W2089536036 @default.
• W2002171031 cites W2106424153 @default.
• W2002171031 cites W2106810380 @default.
• W2002171031 cites W2107405276 @default.
• W2002171031 cites W2114720475 @default.
• W2002171031 cites W2126657029 @default.
• W2002171031 cites W2126739697 @default.
• W2002171031 cites W2133997766 @default.
• W2002171031 cites W2138368231 @default.
• W2002171031 cites W2144081679 @default.
• W2002171031 cites W2150696636 @default.
• W2002171031 cites W2153585273 @default.
• W2002171031 cites W2155496880 @default.
• W2002171031 cites W2156361406 @default.
• W2002171031 cites W2156701434 @default.
• W2002171031 cites W2163056885 @default.
• W2002171031 cites W2469747861 @default.
• W2002171031 cites W4237441795 @default.
• W2002171031 cites W4367011199 @default.
• W2002171031 doi "https://doi.org/10.1017/s0967199406004035" @default.
• W2002171031 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17462101" @default.
• W2002171031 hasPublicationYear "2007" @default.
• W2002171031 type Work @default.
• W2002171031 sameAs 2002171031 @default.
• W2002171031 citedByCount "12" @default.
• W2002171031 countsByYear W20021710312013 @default.
• W2002171031 countsByYear W20021710312015 @default.
• W2002171031 countsByYear W20021710312016 @default.
• W2002171031 countsByYear W20021710312020 @default.
• W2002171031 crossrefType "journal-article" @default.
• W2002171031 hasAuthorship W2002171031A5007691149 @default.
• W2002171031 hasAuthorship W2002171031A5039911435 @default.
• W2002171031 hasAuthorship W2002171031A5061711811 @default.
• W2002171031 hasConcept C105702510 @default.
• W2002171031 hasConcept C16685009 @default.
• W2002171031 hasConcept C181199279 @default.
• W2002171031 hasConcept C185592680 @default.
• W2002171031 hasConcept C196843134 @default.
• W2002171031 hasConcept C202751555 @default.
• W2002171031 hasConcept C2775966511 @default.
• W2002171031 hasConcept C2776609658 @default.
• W2002171031 hasConcept C2776690073 @default.
• W2002171031 hasConcept C2777608289 @default.
• W2002171031 hasConcept C2778177303 @default.
• W2002171031 hasConcept C2778278907 @default.
• W2002171031 hasConcept C2779201268 @default.
• W2002171031 hasConcept C2781087480 @default.
• W2002171031 hasConcept C2994119143 @default.
• W2002171031 hasConcept C512716672 @default.
• W2002171031 hasConcept C538909803 @default.
• W2002171031 hasConcept C55493867 @default.
• W2002171031 hasConcept C71924100 @default.
• W2002171031 hasConcept C86803240 @default.
• W2002171031 hasConcept C87073359 @default.
• W2002171031 hasConcept C88972607 @default.
• W2002171031 hasConcept C95444343 @default.
• W2002171031 hasConcept C98648569 @default.
• W2002171031 hasConceptScore W2002171031C105702510 @default.
• W2002171031 hasConceptScore W2002171031C16685009 @default.
• W2002171031 hasConceptScore W2002171031C181199279 @default.
• W2002171031 hasConceptScore W2002171031C185592680 @default.
• W2002171031 hasConceptScore W2002171031C196843134 @default.
• W2002171031 hasConceptScore W2002171031C202751555 @default.
• W2002171031 hasConceptScore W2002171031C2775966511 @default.

• next